Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Prenatal diagnosis of congenital mesoblastic nephroma

INTRODUCTION

Nearly two thirds of infantile or fetal abdominal masses are of renal origin. Most are benign and related to hydronephrosis and multicystic dysplasia [1]. Congenital renal tumors are rare, comprising 2.5 to 7 percent of all perinatal tumors. This category includes, in decreasing order of frequency, congenital mesoblastic nephroma, Wilms tumor, rhabdoid tumor, clear cell sarcoma, hamartomas (eg, angiomyolipoma), and ossifying tumor of infancy [2].

Congenital mesoblastic nephroma (CMN) arises from renal mesenchyma and is usually benign. It comprises less than 5 percent of all pediatric renal tumors. About 90 percent present in the first year of life, 50 to 75 percent of cases occur in young infants, and almost none occur after the age of 3 years [3]. After 2 months of age, Wilms tumor is more common than CMN. (See "Prenatal sonographic diagnosis of cystic renal disease" and "Presentation, diagnosis, and staging of Wilms tumor".)

PATHOLOGY

CMN is a solitary hamartoma. Mesoblastic nephroma is presumed to originate from proliferating nephrogenic mesenchyme. It is similar in gross and histologic appearance to a uterine leiomyoma with spindled cell sin bundles, but composed of immature renal stromal cells. The tumor lacks renal blastema and neoplastic metanephric elements, thereby differentiating it from Wilms tumor. In addition, it tends to infiltrate the kidney, rather than form the pseudocapsule of classic Wilms tumor.

There are two pathologic variants: classic CMN and atypical or cellular CMN. The classic form is characterized by rare mitoses and absence of necrosis. Dilated vessels and entrapped nephrons are sometimes seen at the periphery of the tumor. Atypical or cellular CMN is characterized by a high mitotic index, hypercellularity, and an atypical growth pattern with necrosis, hemorrhage, and invasion of adjacent structures other than connective tissue [4].

CMN is almost always unilateral and is rarely malignant [5]. It may extend beyond the renal capsule, but rarely metastasizes to distant organs. Cellular CMN, older age, and positive surgical margins appear to increase the risk of recurrence and metastasis [6].

      

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Oct 2014. | This topic last updated: Mar 22, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Glick RD, Hicks MJ, Nuchtern JG, et al. Renal tumors in infants less than 6 months of age. J Pediatr Surg 2004; 39:522.
  2. Isaac, HJ. Tumors. In: Potter's pathology of the fetus and newborn, vol 2, Gilbert Barnes, E (Ed), Mosby, St Louis, MO 1997. p.1242.
  3. Eble, JN, Sauter, G, Epstein, JI, Sesterhenn, IA. Tumours of the urinary system and male genital organs Pathology and genetics. World Health Organization 2004.
  4. Joshi VV, Kasznica J, Walters TR. Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. Arch Pathol Lab Med 1986; 110:100.
  5. Giulian BB. Prenatal ultrasonographic diagnosis of fetal renal tumors. Radiology 1984; 152:69.
  6. Furtwaengler R, Reinhard H, Leuschner I, et al. Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH). Cancer 2006; 106:2275.
  7. Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 1998; 18:184.
  8. Schofield DE, Yunis EJ, Fletcher JA. Chromosome aberrations in mesoblastic nephroma. Am J Pathol 1993; 143:714.
  9. Maymon R, Strauss S, Herman A, et al. The prenatal scan pitfall for the diagnosis of renal mass: case report. Prenat Diagn 2004; 24:932.
  10. Fuchs IB, Henrich W, Brauer M, et al. Prenatal diagnosis of congenital mesoblastic nephroma in 2 siblings. J Ultrasound Med 2003; 22:823.
  11. Goldstein I, Shoshani G, Ben-Harus E, Sujov P. Prenatal diagnosis of congenital mesoblastic nephroma. Ultrasound Obstet Gynecol 2002; 19:209.
  12. Kelner M, Droullé P, Didier F, Hoeffel JC. The vascular "ring" sign in mesoblastic nephroma: report of two cases. Pediatr Radiol 2003; 33:123.
  13. Geller E, Smergel EM, Lowry PA. Renal neoplasms of childhood. Radiol Clin North Am 1997; 35:1391.
  14. Chen WY, Lin CN, Chao CS, et al. Prenatal diagnosis of congenital mesoblastic nephroma in mid-second trimester by sonography and magnetic resonance imaging. Prenat Diagn 2003; 23:927.
  15. Irsutti M, Puget C, Baunin C, et al. Mesoblastic nephroma: prenatal ultrasonographic and MRI features. Pediatr Radiol 2000; 30:147.
  16. van den Heuvel-Eibrink MM, Grundy P, Graf N, et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer 2008; 50:1130.
  17. Leclair MD, El-Ghoneimi A, Audry G, et al. The outcome of prenatally diagnosed renal tumors. J Urol 2005; 173:186.
  18. Liu YC, Mai YL, Chang CC, et al. The presence of hydrops fetalis in a fetus with congenital mesoblastic nephroma. Prenat Diagn 1996; 16:363.